Active?
Facet Toggle
June 27, 2022
While there have been high-level commitments from the World Health Assembly, the United Nations General Assembly (UNGA), the G20, and the G7 to tackle AMR, there has yet to be a fundamental change in how we purchase antimicrobials, or an international approach to improving access, fostering innovati...
September 14, 2020
Led by co-chairs Andrew Powell and Liliana Rojas-Suarez, this working group was the result of a collaboration between CGD and the Inter-American Development Bank. The group was formed by international finance experts and Latin-American and the Caribbean policymakers and prepared a report to be ...
November 15, 2017
International organizations influence national-level health sector priorities by affecting how much funding is available for healthcare delivery within countries and setting limits on how that funding is used. They exert particular influence in setting disease-specific targets, developing clinical g...
September 14, 2017
A new CGD Working Group is assessing the relevance, advantages and challenges for EMDEs’ growth and development and for the stability of their financial systems derived from the implementation of Basel III. Moreover, the Group is advancing specific recommendations regarding components of Basel...
July 31, 2017
Many low-and lower-middle-income countries currently procure a large portion of their health commodities through centralized, donor-managed procurement mechanisms, and often at subsidized prices or as donations. Over the next several decades, however, the landscape of global health procurement will ...